Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749851 · ClinicalTrials.gov registry record
Placenta Imaging Project
A clinical trial of High Risk Pregnancy, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 379
- Enrollment target
- 2
- Study locations
NCT02749851 is a study of High Risk Pregnancy that has completed, run by Oregon Health and Science University. The registered enrollment target is 379 participants, above the 290-participant average among 10 other High Risk Pregnancy trials with a reported enrollment target (31% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT02749851, a study of High Risk Pregnancy, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 379 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the application of newly generated magnetic resonance imaging (MRI) protocols for the assessment of placental perfusion in human subjects. The primary objective is to validate and establish the utility of placental MRI in pregnant women. The study will be entirely MRI-technology based with collection of placental tissue at the time of infant delivery for later correlative studies.
Conditions Studied
Interventions
- DEVICE MRI
- DEVICE MRI - IUGR
Study Locations (2)
Oregon
- Oregon Health and Science University - Portland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2016-10-13 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02749851
The ClinicalTrials.gov registry entry for NCT02749851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 290-participant average among 10 other High Risk Pregnancy trials with a reported enrollment target (31% higher). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High Risk Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT02749851 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oregon, Utah.
Frequently Asked Questions
What is clinical trial NCT02749851 about?
NCT02749851 is a clinical study titled "Placenta Imaging Project". The purpose of this study is to test the application of newly generated magnetic resonance imaging (MRI) protocols for the assessment of placental perfusion in human subjects. The primary objective is to validate and establish the utility of placental MRI in pregnant women. The study will be entirel...
What is the current status of trial NCT02749851?
This trial is currently completed. The enrollment target is 379 participants. The study started on 2016-10-13. Estimated completion is 2020-06-30.
What conditions does trial NCT02749851 study?
This clinical trial studies the following conditions: High Risk Pregnancy.
What interventions are being tested in trial NCT02749851?
The interventions under investigation include: MRI (DEVICE), MRI - IUGR (DEVICE).
Who is sponsoring clinical trial NCT02749851?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02749851 being conducted?
This trial has 2 study locations across Oregon, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Risk Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
Remote Fetal Monitoring in High Risk Pregnancies
RECRUITING
-
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
RECRUITING · Phase 2
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
RECRUITING · NA
-
UCLA Perinatal Biospecimen Repository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.